Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Biora Therapeutics To Carry Out 1-for-10 Reverse Stock Split On October 18th, 2024
October 15th (Eastern Time) - $Biora Therapeutics(BIOR.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from October 18th,
Biora Therapeutics to Reveal 00-Size BioJet Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
Express News | Biora Therapeutics Inc - Approved Reduction in Total Number of Authorized Shares of Common Stock From 300 Mln Shares to 255 Mln Shares
Express News | Biora Therapeutics - Approved Reverse Stock Split of Co's Common Stock, Par Value $0.001 per Share at Ratio of 10:1
12 Health Care Stocks Moving In Tuesday's After-Market Session
Biora Therapeutics' Award-Winning Abstract To Be Presented At American College Of Gastroenterology Annual Meeting
Biora Therapeutics Achieves ISO 13485 Certification, Demonstrating The Co's Commitment To Compliance With The Most Rigorous Global Regulatory And Quality Standards
Express News | Biora Therapeutics Inc - No Payments Will Be Made by Either Party
Express News | Biora Therapeutics - in Sept 2024, Following Hearing on Biora's Summary Judgment Motion, Co and Ravgen Inc Entered Into Settlement Agreement
Biora Therapeutics Granted Extension to Regain Compliance With Nasdaq
Biora Therapeutics Announces Positive Nasdaq Listing Decision
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Express News | Biora Therapeutics Inc Files for Resale of up to 96.7 Mln Shares by the Selling Stockholders - SEC Filing
Biora Therapeutics Second Quarter 2024 Earnings: EPS: US$0.18 (Vs US$1.47 Loss in 2Q 2023)
HC Wainwright & Co. Reiterates Buy on Biora Therapeutics, Maintains $15 Price Target
Biora Therapeutics Analyst Ratings
Syros Pharmaceuticals SYRS Phase 2 Data; Biora Therapeutics BIOR Funding
Biora Therapeutics: Outperforming With Strong Q2 Financials and Clinical Advancements
Earnings Call Summary | Biora Therapeutics(BIOR.US) Q2 2024 Earnings Conference